Beijing Kawin Technology Share-holding Co Ltd (688687) - Net Assets
Based on the latest financial reports, Beijing Kawin Technology Share-holding Co Ltd (688687) has net assets worth CN¥1.75 Billion CNY (≈ $256.31 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.70 Billion ≈ $394.79 Million USD) and total liabilities (CN¥946.31 Million ≈ $138.47 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 688687 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.75 Billion |
| % of Total Assets | 64.92% |
| Annual Growth Rate | 26.81% |
| 5-Year Change | 3.1% |
| 10-Year Change | 218.75% |
| Growth Volatility | 45.4 |
Beijing Kawin Technology Share-holding Co Ltd - Net Assets Trend (2009–2025)
This chart illustrates how Beijing Kawin Technology Share-holding Co Ltd's net assets have evolved over time, based on quarterly financial data. See 688687 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Beijing Kawin Technology Share-holding Co Ltd (2009–2025)
The table below shows the annual net assets of Beijing Kawin Technology Share-holding Co Ltd from 2009 to 2025. For live valuation and market cap data, see market value of Beijing Kawin Technology Share-holding C.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.74 Billion ≈ $254.60 Million |
-7.47% |
| 2024-12-31 | CN¥1.88 Billion ≈ $275.15 Million |
+5.33% |
| 2023-12-31 | CN¥1.79 Billion ≈ $261.23 Million |
+6.15% |
| 2022-12-31 | CN¥1.68 Billion ≈ $246.10 Million |
-0.34% |
| 2021-12-31 | CN¥1.69 Billion ≈ $246.93 Million |
+97.68% |
| 2020-12-31 | CN¥853.63 Million ≈ $124.91 Million |
+10.60% |
| 2019-12-31 | CN¥771.85 Million ≈ $112.95 Million |
+17.86% |
| 2018-12-31 | CN¥654.87 Million ≈ $95.83 Million |
+6.94% |
| 2017-12-31 | CN¥612.36 Million ≈ $89.61 Million |
+12.19% |
| 2015-12-31 | CN¥545.83 Million ≈ $79.87 Million |
+127.69% |
| 2014-12-31 | CN¥239.73 Million ≈ $35.08 Million |
+8.60% |
| 2013-12-31 | CN¥220.74 Million ≈ $32.30 Million |
+34.65% |
| 2012-12-31 | CN¥163.93 Million ≈ $23.99 Million |
+33.78% |
| 2011-12-31 | CN¥122.53 Million ≈ $17.93 Million |
+31.98% |
| 2010-12-31 | CN¥92.84 Million ≈ $13.59 Million |
+138.60% |
| 2009-12-31 | CN¥38.91 Million ≈ $5.69 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Beijing Kawin Technology Share-holding Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 40339929872.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥403.40 Million | 23.63% |
| Other Components | CN¥1.30 Billion | 76.37% |
| Total Equity | CN¥1.71 Billion | 100.00% |
Beijing Kawin Technology Share-holding Co Ltd Competitors by Market Cap
The table below lists competitors of Beijing Kawin Technology Share-holding Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Yest Ltd
KQ:122640
|
$402.99 Million |
|
Bajaj Electricals Limited
NSE:BAJAJELEC
|
$403.07 Million |
|
EVN Finance JSC
VN:EVF
|
$403.11 Million |
|
Key Ware Electronics Co Ltd
TWO:5498
|
$403.12 Million |
|
Fidere Patrimonio SOCIMI SA
MC:YFID
|
$402.97 Million |
|
Yingde Greatchem Chemicals Co. Ltd. A
SHE:300804
|
$402.93 Million |
|
American Battery Technology Company Common Stock
NASDAQ:ABAT
|
$402.91 Million |
|
Jerusalem
TA:JBNK
|
$402.88 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Beijing Kawin Technology Share-holding Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,843,247,304 to 1,707,186,695, a change of -136,060,609 (-7.4%).
- Net income of 29,631,200 contributed positively to equity growth.
- Dividend payments of 56,038,871 reduced retained earnings.
- Other factors decreased equity by 109,652,938.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥29.63 Million | +1.74% |
| Dividends Paid | CN¥56.04 Million | -3.28% |
| Other Changes | CN¥-109.65 Million | -6.42% |
| Total Change | CN¥- | -7.38% |
Book Value vs Market Value Analysis
This analysis compares Beijing Kawin Technology Share-holding Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.64x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 13.00x to 1.64x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-12-31 | CN¥1.24 | CN¥16.11 | x |
| 2010-12-31 | CN¥0.15 | CN¥16.11 | x |
| 2011-12-31 | CN¥1.61 | CN¥16.11 | x |
| 2012-12-31 | CN¥1.99 | CN¥16.11 | x |
| 2013-12-31 | CN¥2.52 | CN¥16.11 | x |
| 2014-12-31 | CN¥2.63 | CN¥16.11 | x |
| 2015-12-31 | CN¥5.34 | CN¥16.11 | x |
| 2017-12-31 | CN¥5.22 | CN¥16.11 | x |
| 2018-12-31 | CN¥5.41 | CN¥16.11 | x |
| 2019-12-31 | CN¥6.34 | CN¥16.11 | x |
| 2020-12-31 | CN¥6.62 | CN¥16.11 | x |
| 2021-12-31 | CN¥10.33 | CN¥16.11 | x |
| 2022-12-31 | CN¥9.84 | CN¥16.11 | x |
| 2023-12-31 | CN¥10.54 | CN¥16.11 | x |
| 2024-12-31 | CN¥11.00 | CN¥16.11 | x |
| 2025-12-31 | CN¥9.79 | CN¥16.11 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Beijing Kawin Technology Share-holding Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.74%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.24%
- • Asset Turnover: 0.47x
- • Equity Multiplier: 1.64x
- Recent ROE (1.74%) is below the historical average (8.94%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 17.76% | 11.67% | 0.85x | 1.79x | CN¥3.02 Million |
| 2010 | 17.17% | 14.50% | 0.67x | 1.78x | CN¥6.66 Million |
| 2011 | 24.23% | 19.70% | 0.72x | 1.71x | CN¥17.44 Million |
| 2012 | 11.53% | 10.09% | 0.58x | 1.98x | CN¥2.41 Million |
| 2013 | 7.94% | 8.51% | 0.50x | 1.88x | CN¥-4.44 Million |
| 2014 | 5.32% | 5.37% | 0.51x | 1.93x | CN¥-10.64 Million |
| 2015 | 4.49% | 8.94% | 0.39x | 1.30x | CN¥-29.35 Million |
| 2017 | 4.40% | 5.47% | 0.68x | 1.19x | CN¥-34.11 Million |
| 2018 | 6.84% | 6.35% | 0.87x | 1.24x | CN¥-20.69 Million |
| 2019 | 6.94% | 6.49% | 0.78x | 1.36x | CN¥-23.66 Million |
| 2020 | 8.91% | 8.77% | 0.74x | 1.38x | CN¥-9.21 Million |
| 2021 | 6.39% | 9.38% | 0.53x | 1.30x | CN¥-60.57 Million |
| 2022 | 4.98% | 7.19% | 0.52x | 1.32x | CN¥-84.15 Million |
| 2023 | 6.64% | 8.25% | 0.58x | 1.40x | CN¥-58.86 Million |
| 2024 | 7.72% | 11.57% | 0.47x | 1.42x | CN¥-41.96 Million |
| 2025 | 1.74% | 2.24% | 0.47x | 1.64x | CN¥-141.09 Million |
Industry Comparison
This section compares Beijing Kawin Technology Share-holding Co Ltd's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,515,802,056
- Average return on equity (ROE) among peers: 9.74%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Beijing Kawin Technology Share-holding Co Ltd (688687) | CN¥1.75 Billion | 17.76% | 0.54x | $402.98 Million |
| Shenzhen CAU Technology Co Ltd (000004) | $105.51 Million | 6.20% | 2.16x | $53.47 Million |
| Pacific Shuanglin Bio pharmacy Co Ltd (000403) | $7.92 Billion | 9.41% | 0.17x | $1.63 Billion |
| Nanhua Bio Medicine Co Ltd (000504) | $128.43 Million | -28.90% | 2.15x | $396.00 Million |
| Jiangsu Sihuan Bioengineering Co Ltd (000518) | $915.76 Million | -0.65% | 0.06x | $483.61 Million |
| Chengzhi Shareholding Co Ltd (000990) | $839.58 Million | 6.67% | 0.90x | $1.61 Billion |
| Hualan Biological EngineeringInc (002007) | $1.14 Billion | 16.37% | 0.10x | $3.45 Billion |
| Da An Gene Co Ltd of Sun Yat-Sen University (002030) | $914.64 Million | 16.73% | 0.74x | $1.10 Billion |
| Shanghai RAAS Blood Products Co Ltd Class A (002252) | $170.01 Million | 48.10% | 0.80x | $4.65 Billion |
| Baolingbao Biology Co Ltd (002286) | $760.53 Million | 7.33% | 0.46x | $512.90 Million |
| Tibet Cheezheng Tibetan Medicine Co Ltd (002287) | $2.26 Billion | 16.10% | 0.32x | $1.71 Billion |
About Beijing Kawin Technology Share-holding Co Ltd
Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhiz… Read more